Abstract Immunosuppressive
drugs and
biological agents may represent a potential
risk of
lymphoma development in
patients with
rheumatoid arthritis. But most cases are diffuse, large
B-cell lymphomas. Primary cutaneous CD4+ small/medium-sized pleomorphic
T-cell lymphoma, a provisional entity in the 2005
WHO-EORTC
classification of cutaneous
lymphomas, is only described in a limited number of
reports. To our
knowledge, our case is a rare instance of primary cutaneous CD4+ small/medium-sized pleomorphic
T-cell lymphoma, after associated
treatment with
methotrexate and
etanercept, in a
patient with moderate
rheumatoid arthritis who had undergone an
orchidectomy incorrectly.